Form 4 Filing for Hepion Pharmaceuticals, Inc.

Vincent S. LoPriore, Executive Chairman, Director, and 10% owner of Hepion Pharmaceuticals, Inc. (HEPA), reported transactions on April 21, 2026. LoPriore acquired 5,000,000 shares of common stock through Gravitas Capital LP at $0.04 per share, and an additional 1,250,000 shares through the Invictus Capital Advisors Pension Plan at $0.04 per share. Following these transactions, LoPriore holds 5,000,000 shares directly through Gravitas Capital LP and 6,250,000 shares through the Pension Plan. The filing indicates these transactions were made at an acquisition price of $0.04 per share.